Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-044293

Director sold 10,000 shares at $13.92 ($139,200)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Guiheen Lawrence P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Exercise or conversion : show line 1 in the form +10,000 $5.00 $50,000 73,599 D
2026-11-16 Sale : show line 2 in the form −10,000 $13.92 $139,200 63,599 D
Open-market sales · 10,000 sh · avg $13.92 · $139,200

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-16 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −10,000 0 D
Loading xslF345X06/form4.xml…